Regeneron Pharmaceuticals Inc Bottom Line Retreats In Q2
(RTTNews) - Regeneron Pharmaceuticals Inc (REGN) revealed a profit for second quarter that Drops, from the same period last year
The company's earnings totaled $1.296 billion, or $12.23 per share. Th
NA
Nasdaq News
30 Jul 2026 5 days ago 1 min read
Nasdaq News โ 30 July 2026
Text:
26 0 0
๐ Translate:
๐๏ธ AI Podcast โ Two-Host Discussion
Regeneron Pharmaceuticals Inc Bottom Line Retreats In Q2
Kokoro TTS ยท ~5 min episode ยท American English voices
Choose voices for Host A and Host B. Changes take effect on next play.
A
Now Speaking
โ
Generating podcastโฆ
Synthesising speech โ will play automatically when readyโฆ
0:00 / 0:00
(RTTNews) - Regeneron Pharmaceuticals Inc (REGN) revealed a profit for second quarter that Drops, from the same period last year